This inventor holds 5 USPTO granted patents. Top assignee: Wako Pure Chemical Industries, Inc.. Active years: 1994-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1998
Title: **Innovator Kazuaki Harada: Pioneering Endotoxin Research**
Introduction
Kazuaki Harada is a notable inventor based in Amagasaki, Japan, recognized for his significant contributions to the field of endotoxin research. With a total of five patented innovations, Harada's work focuses on enhancing the understanding and efficacy of endotoxin inhibition, which is crucial for various biomedical applications.
Latest Patents
Harada's latest patents include innovative processes aimed at inhibiting the activity of endotoxin (ET). His method involves contacting a peptide derivative or a protein that binds to endotoxin, along with at least one surfactant, thereby effectively reducing the activity of endotoxin in the treated sample. This process allows for accurate measurement of endotoxin-like substances without interference from the actual endotoxin present, demonstrating a substantial advancement in toxicology and analytical chemistry.
Career Highlights
Currently affiliated with Wako Pure Chemical Industries, Inc., Kazuaki Harada has demonstrated a remarkable capacity for research and development. His role at the company places him in a pivotal position to influence the landscape of endotoxin research and its applications in pharmaceuticals and healthcare.
Collaborations
During his career, Harada has collaborated with notable colleagues, including Masakazu Tsuchiya and Aya Takaoka. These collaborations have fostered a dynamic research environment, enabling the development of innovative solutions to complex challenges in endotoxin activity measurement.
Conclusion
Kazuaki Harada stands as a distinguished inventor whose work in endotoxin research is making a lasting impact in the scientific community. With his innovative patents and collaborative spirit, he continues to push the boundaries of what is possible, paving the way for future advancements in biomedical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile